QHSLab Inc. introduced Q-Cog™, a cloud-based cognitive assessment tool for early detection of Mild Cognitive Impairment and dementia-related risks.
Q-Cog™ combines cognitive, behavioral, and functional screening in a digital platform to assist primary care providers in identifying at-risk individuals.
An initial real-world pilot identified 54% of patients aged 65 and older with high-risk cognitive scores, emphasizing the need for early detection in primary care.
Q-Cog™ Benefits Primary Care
Q-Cog™ equips primary care clinicians with a patient-friendly digital tool for early identification of at-risk individuals before dementia becomes disabling.
Impact on Diagnosis Rate
Q-Cog™ addresses the persistent diagnostic gap in cognitive impairments, enabling earlier recognition of risks and timely intervention.
Financial Implications for QHSLab
The launch of Q-Cog™ expands QHSLab's reimbursable digital medicine platform, supporting value-based care and improving financial performance for providers.
- Q-Cog™ supports primary care providers in meeting CMS screening guidelines and enhances risk adjustment and reimbursement under neurocognitive codes.
- The tool contributes to more accurate Risk Adjustment Factor (RAF) scoring, improving care outcomes and financial performance for value-based providers.
The introduction of Q-Cog™ represents a significant advancement in early cognitive impairment detection, offering a practical solution for primary care settings and new revenue opportunities for QHSLab.